The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases
Abstract
Background— Erythropoietin (EPO) is a critical regulator for the proliferation of immature erythroid precursors, but its role as a potential cytoprotectant in the cerebrovasculature system has not been defined. Methods and Results— We examined the ability of EPO to regulate a cascade of apoptotic death-related cellular pathways during anoxia-induced vascular injury in endothelial cells (ECs). EC injury was evaluated by trypan blue, DNA fragmentation, membrane phosphatidylserine (PS) exposure, protein kinase B activity, mitochondrial membrane potential, and cysteine protease induction. Exposure to anoxia alone rapidly increased genomic DNA fragmentation from 2±1% to 40±5% and membrane PS exposure from 3±2% to 56±5% over 24 hours. Administration of a cytoprotective concentration of EPO (10 ng/mL) prevented DNA destruction and PS exposure. Cytoprotection by EPO was completely abolished by cotreatment with anti-EPO neutralizing antibody, which suggests that EPO was necessary and sufficient for the prevention of apoptosis. Protection by EPO was intimately dependent on the activation of protein kinase B (Akt1) and the maintenance of mitochondrial membrane potential. Subsequently, EPO inhibited caspase 8-, caspase 1-, and caspase 3-like activities that were linked to mitochondrial cytochrome c release. Conclusions— The present work serves to illustrate that EPO can offer novel cytoprotection during ischemic vascular injury through direct modulation of Akt1 phosphorylation, mitochondrial membrane potential, and cysteine protease activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In vivo evidence that erythropoietin protects neurons from ischemic damage
Sakanaka, M., Wen, T.-C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M., & Sasaki, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4635 · Cited by 949
Akt/Protein Kinase B Inhibits Cell Death by Preventing the Release of Cytochrome c from Mitochondria
Kennedy, S. G., Kandel, E. S., Cross, T. K., & Hay, N. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5800 · Cited by 651
Apoptotic Vascular Endothelial Cells Become Procoagulant
Bombeli, T., Karsan, A., Tait, J. F., & Harlan, J. M. (1997) · Blood · doi:10.1182/blood.v89.7.2429 · Cited by 622
Bernaudin, M., Bellail, A., Marti, H. H., Yvon, A., Vivien, D., Duchatelle, I., Mackenzie, E. T., & Petit, E. (2000) · Glia · doi:10.1002/(sici)1098-1136(200005)30:3<271::aid-glia6>3.0.co;2-h · Cited by 280
Tang, D., Lahti, J. M., & Kidd, V. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9303 · Cited by 248
Chong, Z. Z., Kang, J.-Q., & Maiese, K. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200205000-00001 · Cited by 200
Self-citationEffects of Erythropoietin on Neuronal Activity
Koshimura, K., Murakami, Y., Sohmiya, M., Tanaka, J., & Kato, Y. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722565.x · Cited by 185
Matsushita, H., Morishita, R., Nata, T., Aoki, M., Nakagami, H., Taniyama, Y., Yamamoto, K., Higaki, J., Yasufumi, K., & Ogihara, T. (2000) · Circulation Research · doi:10.1161/01.res.86.9.974 · Cited by 179
Mechanisms Which Mediate the Antiapoptotic Effects of Angiopoietin-1 on Endothelial Cells
Harfouche, R., Hasséssian, H., Guo, Y., Faivre, V., Srikant, C. B., Yancopoulos, G. D., & Hussain, S. N. A. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2421 · Cited by 147
Chong, Z. Z., Lin, S., & Maiese, K. (2002) · Journal of Vascular Research · doi:10.1159/000057762 · Cited by 124
Self-citation
Cited by
Cai, Z., Manalo, D. J., Wei, G., Rodriguez, E. R., Fox-Talbot, K., Lu, H., Zweier, J. L., & Semenza, G. L. (2003) · Circulation · doi:10.1161/01.cir.0000078635.89229.8a · Cited by 557
A novel protective effect of erythropoietin in the infarcted heart
Parsa, C. J., Matsumoto, A., Kim, J., Riel, R. U., Pascal, L. S., Walton, G. B., Thompson, R. B., Petrofski, J. A., Annex, B. H., Stamler, J. S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18200 · Cited by 548
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.004 · Cited by 536
Self-citationNew Avenues of Exploration for Erythropoietin
Maiese, K. (2005) · JAMA · doi:10.1001/jama.293.1.90 · Cited by 528
Self-citationDiabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/582060 · Cited by 424
Metadata
- Authors
- Chong, Z. Z., Kang, J.-Q., & Maiese, K.
- Venue
- Circulation
- Published
- 2002-12-03
- Volume
- 106
- Issue
- 23
- Pages
- 2973-2979
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2161282966
- Cited by
- 381
- References
- 18
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases. https://app.cochat.ai/papers/10.1161/01.cir.0000039103.58920.1f
- The paper
- Chong, Z. Z., Kang, J.-Q., & Maiese, K. (2002). Erythropoietin Is a Novel Vascular Protectant Through Activation of Akt1 and Mitochondrial Modulation of Cysteine Proteases. Circulation. https://doi.org/10.1161/01.cir.0000039103.58920.1f
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.